bioRxivCancer BiologyPreprint
FLIP(L) determines p53 induced life or death
A. Lees, A. J. McIntyre, F. Falcone, N. T. Crawford, C. McCann, G. P. Quinn, J. Z. Roberts, T. Sessler, P. F. Gallagher, K. McAllister, K. McLaughlin, W. L. Allen, C. Holohan, L. J. Egan, A. E. Ryan, M. Labonte-Wilson, P. D. Dunne, M. Wappett, V. M. Coyle, P. Johnston, E. M. Kerr, D. B. Longley, S. S. McDade
Abstract
How p53 differentially activates cell cycle arrest versus cell death remains poorly understood. Here, we demonstrate that upregulation of canonical pro-apoptotic p53 target genes in colon cancer cells imposes a critical dependence on the long splice form of the caspase-8 regulator FLIP (FLIP(L)), which we identify as a direct p53 transcriptional target. Inhibiting FLIP(L) expression with siRNA or Class-I HDAC inhibitors promotes apoptosis in response to p53 activation by the MDM2 inhibitor Nutlin-3A, which otherwise predominantly induces cell-cycle arrest. When FLIP(L) upregulation is inhibited, apoptosis is induced in response to p53 activation via a novel ligand-independent TRAIL-R2/caspase-8 complex, which, by activating BID, induces mitochondrial-mediated apoptosis. Notably, FLIP(L) depletion inhibits p53-induced expression of the cell cycle regulator p21 and enhances p53-mediated upregulation of PUMA, with the latter activating mitochondrial-mediated apoptosis in FLIP(L)-depleted, Nutlin-3A-treated cells lacking TRAIL-R2/caspase-8. Thus, we report two previously undescribed, novel FLIP(L)-dependent mechanisms that determine cell fate following p53 activation.
- organism: human
- research focus: cell signaling & trafficking
- research focus: development & morphogenesis
- research focus: cancer & tumor microenvironment
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tumor suppressor p73 transcriptionally regulates c-FLIP to impede its priming of extrinsic apoptosis while a switcher compound degrades c-FLIP protein
Shengliang Zhang, Lanlan Zhou, Wafik S. El‐Deiry·bioRxiv·Apr 21, 2024
- p53 pro-apoptotic activity is regulated by the G2/M promoting factor Cdk1 in response to DNA damage
Mireya Ruiz-Losada, Raul González, … Carlos Estella·bioRxiv·Feb 13, 2021
- Oncogenic signaling inhibits c-FLIP expression and promotes cancer cell survival during ECM-detachment
M. A. Tsegaye, J. He, … Z. T. Schafer·bioRxiv·Apr 19, 2021
- p53-induced apoptosis is specified by a translation program regulated by PCBP2 and DHX30.
Dario Rizzotto, Sara Zaccara, … Alberto Inga·Cell ReportsPeer-reviewed·Mar 1, 2020
- FLIP is essential for oncogenic KRAS-driven lung cancer
Claudia Hamilton, Shaun Sharkey, … Daniel B. Longley·bioRxiv·Aug 5, 2026
- P-TEFb promotes cell survival upon p53 activation by suppressing intrinsic apoptosis pathway
Z. Wang, M. Macakova, … M. Barboric·bioRxiv·May 29, 2022